Capital Health

Advanced non-invasive liver tumor treatment arriving at Capital Health Cancer Center

Posted

Capital Health Medical Center – Hopewell will be the first and only hospital in the Mercer and Bucks County region to offer histotripsy, a non-invasive treatment option for liver tumors, when the Edison System arrives this summer. Dr. Cataldo Doria, a hepato-pancreato-biliary surgeon and medical director of Capital Health Cancer Center, Dr. Ajay Choudhri, an interventional radiologist and chairman of the Radiology Department at Capital Health, and Dr. Nikhil Thaker, medical director of Radiation Oncology lead the team at the Cancer Center’s Liver Center of Excellence that performs histotripsy in a single outpatient procedure with no cutting or probing. 

Histotripsy is a revolutionary non-invasive solution for patients with liver cancer, including those who are not candidates for surgery or may have previously been told their tumors are inoperable. Dr. Doria and his team use the histotripsy devices to deliver precisely targeted ultrasound pulses that dissolve the diseased liver tumor tissue without piercing the skin. Histotripsy is approved by the U.S. Food and Drug Administration for the treatment of liver tumors, and there are ongoing studies surrounding the use of histotripsy for treating tumors in other areas. As FDA approvals are granted, the team at Capital Health Cancer Center plans to expand their histotripsy program to these new sites.

Capital Health Cancer Center, located at Capital Health Medical Center – Hopewell, is home to the Liver Center of Excellence and centers of excellence specializing in breast care, lung health, neuro-oncology, pancreatic health, and robotic-assisted surgery. To learn more, visit capitalhealthcancer.org/histotripsy. To schedule a histotripsy consultation, call 609-537-6000.